Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer

NuklearMedizin

Volumn 42, Issue 1, 2003, Pages 25-30

  Kotzerke, J ^a,c   Volkmer, B G ^a   Glatting, G ^a   Van den Hoff, J ^b   Gschwend, J E ^a   Messer, P ^a   Reske, S N ^a   Neumaier, B ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b INSTITUTE OF ION BEAM PHYSICS AND MATERIALS RESEARCH   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Acetate; Choline; Positron emission tomography; Prostate cancer

Indexed keywords

ACETIC ACID C 11; CARBON 11; CHOLINE; CHOLINE C 11; TRACER; UNCLASSIFIED DRUG; ACETIC ACID DERIVATIVE; CARBON;

ADULT; AGED; ARTICLE; BONE LESION; BONE METASTASIS; CANCER DIAGNOSIS; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; LYMPH NODE METASTASIS; MALE; METASTASIS; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; BIOPSY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; ECHOGRAPHY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REFERENCE VALUE; SCINTISCANNING; TISSUE DISTRIBUTION; TRANSPORT AT THE CELLULAR LEVEL;

ACETATES; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; BIOPSY; CARBON RADIOISOTOPES; CHOLINE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; REFERENCE VALUES; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037310170     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1623902     Document Type: Article

References (24)

1. Cuadrado A, Carnero A, Dolfi F et al. Phosphorylcholine: a novel second messenger essential for mitogenic activity of growth factors. Oncogene 1993; 8: 2959-68.
2. 11C-choline positron emission tomography. Eur Urol 2002; 42: 18-23.
3. 18F-labeled choline analogs as oncologic PET tracers, J Nucl Med 2001; 42: 1805-14.
4. 18F-fluorocholine. J Nucl Med 2002; 43: 92-6.
5. Dienel GA, Popp D, Drew PD et al. Preferential labeling of glial and meningial brain tumors with [2-(14)C]acetate. J Nucl Med 2001; 42: 1243-50.
6. Effert PJ, Bares R, Handt S et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with fluorine-18labeled deoxyglucose. J Urol 1996; 155: 994-8.
7. Friedland RP, Mathis CA, Budinger TF et al. Labeled choline and phosphorylcholine: body distribution and brain autoradiography: concise communication. J Nucl Med 1983; 24: 812-5.
8. 11C-choline PET. J Nucl Med 2000; 41: 1507-13.
9. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998; 39: 990-5.
10. 11C]choline. J Nucl Med 1997; 38: 842-7.
11. 11C]choline, a positron-emitting tracer for tumor imaging. Appl Radiat Isot 1999; 50: 531-3.
12. 18F-fluorocholine: a new oncologic PET tracer. J Nucl Med 2001; 42: 1815-7.
13. 11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med Mol Imaging 2002; 29: 1492-5.
14. 18F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999; 86: 1638-48.
15. Kotzerke J, Guhlmann A, Moog F et al. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26: 31-8.
16. Kotzerke J, Prang J, Neumaier B et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000; 27: 1415-9.
17. Kotzerke J, Volkmer BG, Neumaier B et al. Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer. Eur J Nucl Med Mol Imaging 2002; 29: 1380-4.
18. Oyama N, Akino H, Kanamaru H et al. 11C-Acetate PET imaging of prostate cancer. J Nucl Med 2002; 43: 181-6.
19. Schmidlin P. Improved iterative image reconstruction using variable projection binning and abbreviated convolution. Eur J Nucl Med 1994; 21: 930-6.
20. Shreve P, Chiao PC, Humes HD et al. Carbon-11-acetate PET imaging in renal disease. J Nucl Med 1995; 36: 1595-601.
21. Shreve PD, Iannone P, Weinhold P. Cellular metabolism of [1-14C]-acetate in prostate cancer cells in vitro. J Nucl Med 2002; 43 (Suppl): 272P.
22. 11C-acetate clearance in nasopharyngeal carcinoma. Nucl Med Commun 1999; 20: 1314.
23. Yoshimoto M, Waki A, Yonekura Y et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001; 28: 117-22.
24. Zeisel SH. Choline phospholipids: signal transduction and carcinogenesis. FASEB J 1993; 7: 551-7.